In conclusion, HLA-DRB1 * 03:01, HLA-DRB1 * 04:01 alleles are reported as risk factors for Jordanians MS patients, according to our analysis of the HLA class II immunogenetic profile of MS patients in Jordan. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.